240 related articles for article (PubMed ID: 16714211)
1. Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients.
Stio M; Martinesi M; Bruni S; Treves C; d'Albasio G; Bagnoli S; Bonanomi AG
Int Immunopharmacol; 2006 Jul; 6(7):1083-92. PubMed ID: 16714211
[TBL] [Abstract][Full Text] [Related]
2. Biochemical effects of KH 1060 and anti-TNF monoclonal antibody on human peripheral blood mononuclear cells.
Stio M; Treves C; Martinesi M; Bonanomi AG
Int Immunopharmacol; 2005 Apr; 5(4):649-59. PubMed ID: 15710334
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of adhesion molecules and matrix metalloproteinases by ZK 156979 in inflammatory bowel diseases.
Martinesi M; Treves C; Bonanomi AG; Milla M; Bagnoli S; Zuegel U; Steinmeyer A; Stio M
Clin Immunol; 2010 Jul; 136(1):51-60. PubMed ID: 20399147
[TBL] [Abstract][Full Text] [Related]
4. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease.
Laverny G; Penna G; Vetrano S; Correale C; Nebuloni M; Danese S; Adorini L
Immunol Lett; 2010 Jun; 131(1):49-58. PubMed ID: 20350569
[TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis.
Stio M; Treves C; Celli A; Tarantino O; d'Albasio G; Bonanomi AG
Am J Gastroenterol; 2002 Mar; 97(3):679-89. PubMed ID: 11922564
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D derivatives induce apoptosis and downregulate ICAM-1 levels in peripheral blood mononuclear cells of inflammatory bowel disease patients.
Martinesi M; Treves C; d'Albasio G; Bagnoli S; Bonanomi AG; Stio M
Inflamm Bowel Dis; 2008 May; 14(5):597-604. PubMed ID: 18200516
[TBL] [Abstract][Full Text] [Related]
8. Serum tumor necrosis factor activity in inflammatory bowel disease.
Maeda M; Watanabe N; Neda H; Yamauchi N; Okamoto T; Sasaki H; Tsuji Y; Akiyama S; Tsuji N; Niitsu Y
Immunopharmacol Immunotoxicol; 1992; 14(3):451-61. PubMed ID: 1517530
[TBL] [Abstract][Full Text] [Related]
9. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context.
Vadori M; Seveso M; Besenzon F; Bosio E; Tognato E; Fante F; Boldrin M; Gavasso S; Ravarotto L; Mann BE; Simioni P; Ancona E; Motterlini R; Cozzi E
Xenotransplantation; 2009; 16(2):99-114. PubMed ID: 19392725
[TBL] [Abstract][Full Text] [Related]
11. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease.
Zhu Y; Mahon BD; Froicu M; Cantorna MT
Eur J Immunol; 2005 Jan; 35(1):217-24. PubMed ID: 15593122
[TBL] [Abstract][Full Text] [Related]
12. Effects of tumor necrosis factor alpha inhibition with infliximab on lipid levels and insulin resistance in patients with inflammatory bowel disease.
Koutroubakis IE; Oustamanolakis P; Malliaraki N; Karmiris K; Chalkiadakis I; Ganotakis E; Karkavitsas N; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):283-8. PubMed ID: 19279474
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
Siddique I; Hasan F; Khan I
Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
[TBL] [Abstract][Full Text] [Related]
14. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
Baumgart DC; Metzke D; Schmitz J; Scheffold A; Sturm A; Wiedenmann B; Dignass AU
Gut; 2005 Feb; 54(2):228-36. PubMed ID: 15647187
[TBL] [Abstract][Full Text] [Related]
15. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.
Danese S
Dig Liver Dis; 2008 Jul; 40 Suppl 2():S225-8. PubMed ID: 18598993
[TBL] [Abstract][Full Text] [Related]
17. A carbocyclic nucleoside analogue is a TNF-alpha inhibitor with immunosuppressive action: role of prostaglandin E2 and protein kinase C and comparison with pentoxifylline.
Al-Humidan A; Edwards CK; Al-Sofi A; Dzimiri M; Al-Sedairy ST; Khabar KS
Cell Immunol; 1998 Aug; 188(1):12-8. PubMed ID: 9743553
[TBL] [Abstract][Full Text] [Related]
18. 22-ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities.
Daniel C; Schlauch T; Zügel U; Steinmeyer A; Radeke HH; Steinhilber D; Stein J
Eur J Clin Invest; 2005 May; 35(5):343-9. PubMed ID: 15860047
[TBL] [Abstract][Full Text] [Related]
19. The Vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease.
Stio M; Martinesi M; Bruni S; Treves C; Mathieu C; Verstuyf A; d'Albasio G; Bagnoli S; Bonanomi AG
J Steroid Biochem Mol Biol; 2007 Jan; 103(1):51-60. PubMed ID: 17049230
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue.
Hassan MI; Kassim SK; Saeda L; Laban M; Khalifa A
Anticancer Res; 1999; 19(6C):5657-62. PubMed ID: 10697636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
